GDTC logo

GDTC
CYTOMED THERAPEUTICS LIMITED

338
Mkt Cap
$13.73M
Volume
97,239.00
52W High
$3.68
52W Low
$0.6801
PE Ratio
-4.44
GDTC Fundamentals
Price
$1.16
Prev Close
$0.8802
Open
$0.95
50D MA
$0.99
Beta
0.55
Avg. Volume
6,608.85
EPS (Annual)
-$0.2616
P/B
2.70
Rev/Employee
$5,911.17
$14.54
Loading...
Loading...
News
all
press releases
News Placeholder
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge PR Newswire VANCOUVER, BC, Oct. 15, 2025 Equity Insider News...
PR Newswire·7mo ago
News Placeholder
Why Did CytoMed Therapeutics Stock Jump 19% Today?
The company said that the proposed acquisition of TC BioPharm will strengthen and deepen its expertise and knowledge in using allogeneic cell therapies for cancer treatment.
Stocktwits·7mo ago
<
...
1
>

Latest GDTC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.